Norvic International Hospital Postpones AGM to Approve Dividend and IPO Plans
14th September 2025, Kathmandu
Norvic International Hospital, a leading private healthcare provider in Nepal, has officially postponed its Annual General Meeting (AGM) due to the ongoing challenging circumstances and safety concerns across the country.
Norvic Hospital Postpones AGM
The meeting was originally scheduled to be held today, on Bhadra 29, 2082 (September 14, 2025). In an official notice to its shareholders and the Nepal Stock Exchange (NEPSE), the hospital cited the “unfavorable and unsafe situation” resulting from recent nationwide protests as the key reason for the delay. A new date for the AGM will be announced once the situation returns to a secure and stable state, ensuring the well-being of all investors, staff, and stakeholders.
Significant Agenda Items on Hold
The postponed AGM was set to address several high-profile proposals of significant interest to the investment community. The key agendas, which are now on hold, included:
Dividend Approval: The board had proposed a substantial dividend package for the fiscal year 2081/82. This included a 40% bonus share distribution to reward shareholders for the hospital’s strong financial performance. Additionally, a 2.105% cash dividend was proposed specifically to cover the tax obligations arising from the bonus shares, demonstrating a commitment to enhancing shareholder value in a fiscally responsible manner.
Initial Public Offering (IPO): One of the most anticipated items on the agenda was the plan to issue an IPO equivalent to 20% of the company’s paid-up capital to the general public. This strategic move would not only allow broader public participation in the hospital’s ownership but also help raise additional capital for future expansion and growth initiatives, reinforcing Norvic’s position in Nepal’s healthcare landscape.
Corporate Governance: The AGM was also planned to include standard but crucial governance items, such as the approval of the board of directors’ annual report and the auditor’s report, as well as the appointment of an external auditor for the current fiscal year (2025/26). These steps are essential for maintaining financial transparency and regulatory compliance.
Implications for Shareholders and the Market
The postponement, while a temporary setback, is a responsible measure taken to protect all parties involved. For investors, it means that the highly anticipated decisions on the bonus shares and the IPO are temporarily suspended. This move mirrors a broader trend in Nepal where many companies have delayed public events and shareholder meetings in the wake of recent political and social unrest. This cautious approach is aimed at maintaining investor confidence during a period of uncertainty. Investors will need to closely monitor the hospital’s official communications and NEPSE announcements for updates on the new meeting date. The eligibility for participation, based on the Bhadra 9 book closure date, remains unchanged, so those who were shareholders at that time will be the ones eligible to attend and vote when the meeting is finally held.
Broader Sector Context
The healthcare sector in Nepal is a rapidly growing market, driven by increasing demand for high-quality private medical services. Norvic International Hospital’s strong financial performance and ambitious plans for expansion, highlighted by the proposed IPO, underscore its position as a key player in this dynamic industry. The eventual approval of its bonus share issuance and IPO is expected to attract significant interest from both institutional and retail investors. This development could mark a turning point, not just for Norvic but for the entire healthcare investment landscape in Nepal. By prioritizing safety and transparency, the hospital is demonstrating its commitment to its stakeholders and its long-term vision for growth, a quality essential for success in a competitive market.
For More: Norvic Hospital Postpones AGM
